Although NCAM1 is thought to be involved in several processes, like neuronal development, organization of synapses and myelination/remyelination process, that take place in MS (Massaro 2002), data concerning plasma levels of NCAM1 in MS patients are not available in literature. This evidence concerns the gene NCAM1 and myeloid sarcoma.